Cargando…
Impact of differing methodologies for serum miRNA-371a-3p assessment in stage I testicular germ cell cancer recurrence
INTRODUCTION: Current evidence shows that serum miR-371a-3p can identify disease recurrence in testicular germ cell tumour (TGCT) patients and correlates with tumour load. Despite convincing evidence showing the advantages of including miR-371a-3p testing to complement and overcome the classical ser...
Autores principales: | Christiansen, Ailsa J., Lobo, João, Fankhauser, Christian D., Rothermundt, Christian, Cathomas, Richard, Batavia, Aashil A., Grogg, Josias B., Templeton, Arnoud J., Hirschi-Blickenstorfer, Anita, Lorch, Anja, Gillessen, Silke, Moch, Holger, Beyer, Jörg, Hermanns, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773982/ https://www.ncbi.nlm.nih.gov/pubmed/36568207 http://dx.doi.org/10.3389/fonc.2022.1056823 |
Ejemplares similares
-
Metastatic Potential of Small Testicular Germ Cell Tumors: Implications for Surveillance of Small Testicular Masses
por: Pratsinis, Manolis, et al.
Publicado: (2022) -
The Value of Tumour Markers in the Detection of Relapse—Lessons Learned from the Swiss Austrian German Testicular Cancer Cohort Study
por: Fischer, Stefanie, et al.
Publicado: (2023) -
Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study
por: Dieckmann, Klaus-Peter, et al.
Publicado: (2019) -
Oncological and functional outcomes after testis-sparing surgery in patients with germ cell tumors: a systematic review of 285 cases
por: Grogg, Josias Bastian, et al.
Publicado: (2022) -
Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data
por: Grogg, Josias Bastian, et al.
Publicado: (2020)